Tell a good IP story and investors are interested in funding your start-up. Tell them the same old “we’ve got a great product and no competition” and they’ll probably walk away. Your intellectual property is directly linked to the future success and revenues of your start-up. You’ve got little or […]
DSL created a multi-billion dollar industry. It was launched into the market by a startup who licensed the technology from a top US university. The IP changed the internet and catapulted this startup into a a world leader. For startups, developing an IP from the ground up is an expensive and risky endeavor. But there is a better way to launch a startup.
Medical device technology is one of the biggest industries in health care, and growing demand for state-of-the-art consumer medical devices is driving this explosive growth. It’s an industry that is becoming a high-volume consumer electronics market in which technical innovation, cost control and IP are critical to commercial success. It’s also a very competitive industry and succeeding requires staying informed on the best practices for product development, marketing, sales, financing, IP management and licensing.
One of the most important and overlooked areas of your start-up is intellectual property. It’s often your most important core asset and the difference between your success and failure in the market. But the question is whether your start-up is managing your IP the right way to succeed in the commercial marketplace. Get it wrong, and your start-up is doomed to failure. Here are top 4 fatal IP mistakes and how your start-up can avoid them.
Figuring out the right exit path and a specific plan to get there is challenging. As a startup, you face many unknown variables in regards to how successful you’ll be in the market. It can’t be done effectively without careful analysis and a clear, realistic vision. Without exception the objective is to sell for the highest possible price. But the problem is most startups often provide overly optimistic or unrealistic assessments of their exit options, and wind up turning off investors.